Clinical Trial Update: Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) [Phase 2]

View source ↗

Summary

A Phase 2 trial at Kyoto University Hospital is evaluating pembrolizumab with enfortumab vedotin and radiation therapy for muscle-invasive bladder cancer, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• Enfortumab Vedotin (Padcev) (enfortumab vedotin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Kyoto University Hospital | Conditions: Bladder Cancer | Phase 2 | Status: RECRUITING